Cellular and Molecular Mechanisms in Gynecological Disorders

book OA: gold CC0
📄 Open PDF View on OpenAlex View at publisher

Abstract

Gynecological disorders encompass a broad spectrum of conditions affecting the female reproductive organs, including the uterus, ovaries, fallopian tubes, cervix, vagina, and external genitalia. These diseases impose a major health and financial burden worldwide, causing significant morbidity and profoundly affecting womens quality of life. Despite their prevalence, the underlying etiologies are often complex and remain only partially understood, with limited knowledge of the risk factors that contribute to disease onset and progression. Advancing our understanding of the cellular and molecular mechanisms driving these disorders is therefore essential for developing more effective strategies for prevention, diagnosis, and treatment.This collection of original research and review articles provides a comprehensive overview of emerging insights into ovarian and uterine pathologies, reflecting the interconnected nature of gynecologic conditions. Topics addressed include mesothelial clearance by endometriosis spheroids, impaired decidualization, autophagy in reproductive aging, protease regulation in ovarian function, immunetumor interactions in ovarian cancer, and the molecular drivers of fibrosis, senescence, cellular transformation, and tumorigenesis in uterine tissues. Collectively, these contributions underscore the urgent need for integrative research efforts that bridge basic science and clinical application, ultimately advancing the field toward improved outcomes for women affected by gynecologic diseases.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK